{"entity":{"type":"insider","cik":"0001389147","url":"/insider/0001389147","json_url":"/insider/0001389147.json","name":"DILLY STEPHEN GEORGE","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":16,"first":"2016-11-15","last":"2023-09-12","span_basis":"filed_date"},"name_variants":[{"name":"DILLY STEPHEN GEORGE","source":"filing","n_filings":16,"first_seen":"2016-11-15","last_seen":"2023-09-12"}],"transactions":[{"id":8528700,"accession":"0000905148-23-000900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-23-000900","line_url":"/filing/0000905148-23-000900#line-1","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS, INC.","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58479.0,"shares_display":"58,479","price_per_share":1.7263,"price_display":"1.73","price_state":"stated","total_value":100952.2977,"total_display":"100,952.30","total_whole":"100,952","shares_owned_after":438878.0,"shares_owned_after_display":"438,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-08","filed_date":"2023-09-12","scope":"insider"},{"id":8024541,"accession":"0001567619-23-004772","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-23-004772","line_url":"/filing/0001567619-23-004772#line-3","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS, INC.","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26987.0,"shares_display":"26,987","price_per_share":4.5552,"price_display":"4.56","price_state":"stated","total_value":122931.1824,"total_display":"122,931.18","total_whole":"122,931","shares_owned_after":380399.0,"shares_owned_after_display":"380,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-08","filed_date":"2023-03-09","scope":"insider"},{"id":8024540,"accession":"0001567619-23-004772","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-23-004772","line_url":"/filing/0001567619-23-004772#line-2","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS, INC.","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28088.0,"shares_display":"28,088","price_per_share":4.6027,"price_display":"4.60","price_state":"stated","total_value":129280.6376,"total_display":"129,280.64","total_whole":"129,281","shares_owned_after":407386.0,"shares_owned_after_display":"407,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-09","scope":"insider"},{"id":5522556,"accession":"0001209191-21-034601","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034601","line_url":"/filing/0001209191-21-034601#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (CEO and President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO and President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":17.83,"price_display":"17.83","price_state":"stated","total_value":89150.0,"total_display":"89,150.00","total_whole":"89,150","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-19","filed_date":"2021-05-20","scope":"insider"},{"id":3312060,"accession":"0001209191-20-020483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020483","line_url":"/filing/0001209191-20-020483#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":210000.0,"total_display":"210,000.00","total_whole":"210,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-19","filed_date":"2020-03-20","scope":"insider"},{"id":3039739,"accession":"0001209191-20-020143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020143","line_url":"/filing/0001209191-20-020143#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.0174,"price_display":"6.02","price_state":"stated","total_value":90261.0,"total_display":"90,261.00","total_whole":"90,261","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":6887930,"accession":"0000899243-18-016350","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-016350","line_url":"/filing/0000899243-18-016350#line-2","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29457.0,"shares_display":"29,457","price_per_share":30.8348,"price_display":"30.83","price_state":"stated","total_value":908300.7036,"total_display":"908,300.70","total_whole":"908,301","shares_owned_after":315308.0,"shares_owned_after_display":"315,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-11","filed_date":"2018-06-13","scope":"insider"},{"id":6381465,"accession":"0000899243-18-015796","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-18-015796","line_url":"/filing/0000899243-18-015796#line-7","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42106.0,"shares_display":"42,106","price_per_share":30.6966,"price_display":"30.70","price_state":"stated","total_value":1292511.0396,"total_display":"1,292,511.04","total_whole":"1,292,511","shares_owned_after":315308.0,"shares_owned_after_display":"315,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-08","scope":"insider"},{"id":6381458,"accession":"0000899243-18-015796","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-015796","line_url":"/filing/0000899243-18-015796","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32598.0,"shares_display":"32,598","price_per_share":30.95621685379471,"price_display":"30.96","price_state":"stated","total_value":1009110.757,"total_display":"1,009,110.76","total_whole":"1,009,111","shares_owned_after":315808.0,"shares_owned_after_display":"315,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-07","filed_date":"2018-06-08","scope":"insider","n_lines":2},{"id":6381450,"accession":"0000899243-18-015796","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-015796","line_url":"/filing/0000899243-18-015796#line-2","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30465.0,"shares_display":"30,465","price_per_share":31.1955,"price_display":"31.20","price_state":"stated","total_value":950370.9075,"total_display":"950,370.91","total_whole":"950,371","shares_owned_after":315308.0,"shares_owned_after_display":"315,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-06","filed_date":"2018-06-08","scope":"insider"},{"id":6407624,"accession":"0000899243-18-015156","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-18-015156","line_url":"/filing/0000899243-18-015156#line-12","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38825.0,"shares_display":"38,825","price_per_share":31.8309,"price_display":"31.83","price_state":"stated","total_value":1235834.6925,"total_display":"1,235,834.69","total_whole":"1,235,835","shares_owned_after":315308.0,"shares_owned_after_display":"315,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-05","scope":"insider"},{"id":6407618,"accession":"0000899243-18-015156","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000899243-18-015156","line_url":"/filing/0000899243-18-015156","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65352.0,"shares_display":"65,352","price_per_share":31.87898742196107,"price_display":"31.88","price_state":"stated","total_value":2083355.586,"total_display":"2,083,355.59","total_whole":"2,083,356","shares_owned_after":317920.0,"shares_owned_after_display":"317,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-04","filed_date":"2018-06-05","scope":"insider","n_lines":2},{"id":6407612,"accession":"0000899243-18-015156","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-18-015156","line_url":"/filing/0000899243-18-015156","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61197.0,"shares_display":"61,197","price_per_share":32.615862810268474,"price_display":"32.62","price_state":"stated","total_value":1995992.9564,"total_display":"1,995,992.96","total_whole":"1,995,993","shares_owned_after":317806.0,"shares_owned_after_display":"317,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-01","filed_date":"2018-06-05","scope":"insider","n_lines":2},{"id":5114145,"accession":"0000899243-17-024684","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-024684","line_url":"/filing/0000899243-17-024684","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":33.54538102,"price_display":"33.55","price_state":"stated","total_value":3354538.102,"total_display":"3,354,538.10","total_whole":"3,354,538","shares_owned_after":339840.0,"shares_owned_after_display":"339,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-23","filed_date":"2017-10-25","scope":"insider","n_lines":4},{"id":4524315,"accession":"0000899243-17-024448","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-024448","line_url":"/filing/0000899243-17-024448#line-1","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1154.0,"shares_display":"1,154","price_per_share":26.238,"price_display":"26.24","price_state":"stated","total_value":30278.652,"total_display":"30,278.65","total_whole":"30,279","shares_owned_after":415308.0,"shares_owned_after_display":"415,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-18","scope":"insider"},{"id":4256741,"accession":"0000899243-17-023786","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-17-023786","line_url":"/filing/0000899243-17-023786#line-4","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4047.0,"shares_display":"4,047","price_per_share":26.308,"price_display":"26.31","price_state":"stated","total_value":106468.476,"total_display":"106,468.48","total_whole":"106,468","shares_owned_after":416462.0,"shares_owned_after_display":"416,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-06","scope":"insider"},{"id":4256737,"accession":"0000899243-17-023786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-17-023786","line_url":"/filing/0000899243-17-023786#line-3","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14689.0,"shares_display":"14,689","price_per_share":26.2438,"price_display":"26.24","price_state":"stated","total_value":385495.1782,"total_display":"385,495.18","total_whole":"385,495","shares_owned_after":420509.0,"shares_owned_after_display":"420,509","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-06","scope":"insider"},{"id":4256735,"accession":"0000899243-17-023786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-023786","line_url":"/filing/0000899243-17-023786","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80110.0,"shares_display":"80,110","price_per_share":26.230849144925728,"price_display":"26.23","price_state":"stated","total_value":2101353.325,"total_display":"2,101,353.32","total_whole":"2,101,353","shares_owned_after":465308.0,"shares_owned_after_display":"465,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-04","filed_date":"2017-10-06","scope":"insider","n_lines":2},{"id":5282975,"accession":"0000899243-17-022644","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-17-022644","line_url":"/filing/0000899243-17-022644#line-9","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":25.0079,"price_display":"25.01","price_state":"stated","total_value":2500790.0,"total_display":"2,500,790.00","total_whole":"2,500,790","shares_owned_after":515308.0,"shares_owned_after_display":"515,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-25","filed_date":"2017-09-27","scope":"insider"},{"id":4069049,"accession":"0000899243-17-019292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-019292","line_url":"/filing/0000899243-17-019292#line-1","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":21.4622,"price_display":"21.46","price_state":"stated","total_value":1073110.0,"total_display":"1,073,110.00","total_whole":"1,073,110","shares_owned_after":615308.0,"shares_owned_after_display":"615,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-26","filed_date":"2017-07-28","scope":"insider"},{"id":4439162,"accession":"0000899243-17-017282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-017282","line_url":"/filing/0000899243-17-017282#line-1","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49400.0,"shares_display":"49,400","price_per_share":20.2144,"price_display":"20.21","price_state":"stated","total_value":998591.36,"total_display":"998,591.36","total_whole":"998,591","shares_owned_after":665308.0,"shares_owned_after_display":"665,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-23","filed_date":"2017-06-27","scope":"insider"},{"id":5152106,"accession":"0000899243-17-012977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-012977","line_url":"/filing/0000899243-17-012977#line-1","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":20.15,"price_display":"20.15","price_state":"stated","total_value":12090.0,"total_display":"12,090.00","total_whole":"12,090","shares_owned_after":714708.0,"shares_owned_after_display":"714,708","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-10","filed_date":"2017-05-12","scope":"insider"},{"id":2641517,"accession":"0000899243-16-033506","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-16-033506","line_url":"/filing/0000899243-16-033506","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48696.0,"shares_display":"48,696","price_per_share":25.012116609167077,"price_display":"25.01","price_state":"stated","total_value":1217990.0304,"total_display":"1,217,990.03","total_whole":"1,217,990","shares_owned_after":715308.0,"shares_owned_after_display":"715,308","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-11","filed_date":"2016-11-15","scope":"insider","n_lines":2},{"id":2641506,"accession":"0000899243-16-033506","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-16-033506","line_url":"/filing/0000899243-16-033506#line-9","is_derivative":false,"issuer_cik":"0001389147","issuer_name":"Aimmune Therapeutics, Inc.","issuer_ticker":"AIMT","issuer_name_source":null,"issuer_url":"/issuer/0001389147","owner_cik":"0001389147","owner_name":"DILLY STEPHEN GEORGE","owner_display_name":"DILLY STEPHEN GEORGE","owner_url":"/insider/0001389147","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock, $0.0001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1304.0,"shares_display":"1,304","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":32600.0,"total_display":"32,600.00","total_whole":"32,600","shares_owned_after":764004.0,"shares_owned_after_display":"764,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-10","filed_date":"2016-11-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS, INC.","url":"/issuer/0001200375","role":"Director, Officer","n_filings":2,"first_seen":"2023-03-09","last_seen":"2023-09-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Director, Officer (CEO and President)","n_filings":1,"first_seen":"2021-05-20","last_seen":"2021-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Director","n_filings":2,"first_seen":"2020-03-18","last_seen":"2020-03-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001631650","name":"Aimmune Therapeutics, Inc.","url":"/issuer/0001631650","role":"Director, Officer (President and CEO)","n_filings":11,"first_seen":"2016-11-15","last_seen":"2018-06-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001389147","retrieved_at":"2026-08-24T20:11:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}